New guidelines for stage III melanoma (the French Cutaneous Oncology Group)
| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | New guidelines for stage III melanoma (the French Cutaneous Oncology Group) |
| Type de publication | Journal Article |
| Year of Publication | 2019 |
| Auteurs | Guillot B., Dupuy A., Pracht M., Jeudy G., Hindie E., Desmedt E., Jouary T., Leccia M-T |
| Journal | ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE |
| Volume | 146 |
| Pagination | 204-214 |
| Date Published | MAR |
| Type of Article | Article |
| ISSN | 0151-9638 |
| Mots-clés | guidelines, Immunotherapy, sentinel node, Stage III melanoma, Targeted therapy |
| Résumé | Improved knowledge of sentinel node procedures coupled with the results of adjuvant clinical trials in stage III melanoma have prompted the French Cutaneous Oncology Group to propose new guidelines for the management of stage III melanoma. These guidelines comply with the principles of the evidence-based medicine. (C) 2019 Elsevier Masson SAS. All rights reserved. |
| DOI | 10.1016/j.annder.2019.01.011 |